Literature DB >> 10719695

Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma.

S Wachter1, N Gerstner, G Goldner, R Pötzi, A Wambersie, R Pötter.   

Abstract

PURPOSE: To describe rectal mucosal damage in an endoscopic study after conformal radiotherapy of prostate cancer and to correlate this with clinical outcome.
MATERIALS AND METHODS: Flexible rectosigmoidoscopy was performed on 44 patients who voluntarily accepted the examination. The median follow-up was 29 months (20-41 months) after 3-D-planned conformal radiotherapy of prostate cancer (66 Gy at the ICRU Reference point, 2 Gy per fraction). To enable a systematic topographic description of endoscopic findings the rectum was divided into four sections. Additionally we differentiated between anterior, posterior, right and left lateral rectal wall. Due to the lack of an existing valid graduation system for radiation induced proctitis, we introduced a six-scaled rectoscopy score for describing and reporting endoscopic findings based on the standardization of the endoscopic terminology published by the ESGE (European Society for Gastrointestinal Endoscopy). Endoscopic findings were compared to the EORTC/RTOG morbidity score. In addition, since 3-D dose distribution of organs at risks was available, a correlation could be made between the location of the rectal lesions and the absorbed dose at that level.
RESULTS: In general, endoscopic findings increased from the proximal rectum to the anorectal transition, as well as from the posterior to the anterior rectum wall. Telangiectasia grade 1 and 2 were observed at the whole circumference, only telangiectasia grade 3 were limited to the high dose region at the anterior rectum wall. Similar results were found for congested mucosa (reddening and edematous mucosa). Correlation with symptoms, 7/9 patients who suffered from intermittent rectal bleeding (EORTC/RTOG grade 2) had multiple telangiectasia grade 2-3 and/or congested mucosa grade 3 and microulcerations. However, the same extent of mucosal damage (rectoscopy score 2-3) was found in seven out of 35 patients who have never developed a period of macroscopic rectal bleeding.
CONCLUSION: Rectoscopy offers the possibility of detecting signs of tissue dysfunction below the level of subjective symptoms. Systematic analytic examinations such as rectoscopy, in addition to clinical examinations, as already foreseen in the LENT-SOMA-score, will be necessary due to the fact that even telangiectatic lesions have been observed for asymptomatic patients. For the opportunity of sharing and comparing data collected from endoscopy after radiotherapy a graduation system as proposed based on a standardisation of the endoscopic terminology will be necessary.

Entities:  

Mesh:

Year:  2000        PMID: 10719695     DOI: 10.1016/s0167-8140(99)00173-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  37 in total

1.  3-D Conformal radiotherapy of localized prostate cancer within an Austrian-German multicenter trial: a prospective study of patients' acceptance of the rectal balloon during treatment.

Authors:  Gregor Goldner; Hans Geinitz; Stefan Wachter; Gerd Becker; Frank Zimmermann; Natascha Wachter-Gerstner; Stefan Glocker; Regina Pötzi; Andre Wambersie; Michael Bamberg; Michael Molls; Horst Feldmann; Richard Pötter
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

2.  Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Authors:  Alexei Trofimov; Paul L Nguyen; John J Coen; Karen P Doppke; Robert J Schneider; Judith A Adams; Thomas R Bortfeld; Anthony L Zietman; Thomas F Delaney; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-21       Impact factor: 7.038

3.  Colostomy is a simple and effective procedure for severe chronic radiation proctitis.

Authors:  Zi-Xu Yuan; Teng-Hui Ma; Huai-Ming Wang; Qing-Hua Zhong; Xi-Hu Yu; Qi-Yuan Qin; Jian-Ping Wang; Lei Wang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 4.  Radiation proctopathy.

Authors:  Marc B Grodsky; Shafik M Sidani
Journal:  Clin Colon Rectal Surg       Date:  2015-06

5.  Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

Authors:  J Andreyev
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

6.  Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy.

Authors:  Gregor Goldner; Richard Pötter; Alexander Kranz; Alexandra Bluhm; Wolfgang Dörr
Journal:  Strahlenther Onkol       Date:  2011-02-24       Impact factor: 3.621

Review 7.  Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists.

Authors:  Ann C Muls; Lorraine Watson; Clare Shaw; H Jervoise N Andreyev
Journal:  Frontline Gastroenterol       Date:  2012-10-02

Review 8.  Systematic review: anal and rectal changes after radiotherapy for prostate cancer.

Authors:  Robin Krol; Robert Jan Smeenk; Emile N J T van Lin; Eric E K Yeoh; Wim P M Hopman
Journal:  Int J Colorectal Dis       Date:  2013-10-23       Impact factor: 2.571

9.  Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.

Authors:  Oscar Acosta; Gael Drean; Juan D Ospina; Antoine Simon; Pascal Haigron; Caroline Lafond; Renaud de Crevoisier
Journal:  Phys Med Biol       Date:  2013-03-26       Impact factor: 3.609

10.  Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score.

Authors:  Nicole L Simone; Cynthia Ménard; Benjamin P Soule; Paul S Albert; Peter Guion; Sharon Smith; Denise Godette; Nancy S Crouse; Linda C Sciuto; Theresa Cooley-Zgela; Kevin Camphausen; C Norman Coleman; Anurag K Singh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-12       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.